*ST聯合(600358.SH):新線中視的業績承諾人完成2019年度業績補償
格隆匯 11 月 8日丨*ST聯合(600358.SH)公佈,2020年9月30日,公司與業績承諾人毅煒投資、盧鬱煒簽署了《關於新線中視2019年度利潤補償的實施協議》,各方一致同意以毅煒投資持有的新線中視股權向公司進行補償。毅煒投資向國旅聯合無償轉讓所持新線中視6.9305%股權,以履行業績承諾人2019年的業績補償義務。
2020年11月5日,新線中視完成將毅煒投資所持新線中視6.9305%股權過户至國旅聯合的相關工商變更登記,公司合計持有新線中視的股權比例為57.9305%。至此,業績承諾人毅煒投資、盧鬱煒因新線中視2019年未完成利潤承諾事項的業績補償義務已履行完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.